Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea
· Delayed Price · Currency is KRW 9,280.00
+20.00 (0.22%)
At close: Mar 10, 2026
Hyundai Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is December - November.
Millions KRW. Fiscal year is Dec - Nov.
Fiscal Year | Current | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2004 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 | 2008 - 2004 |
| Market Capitalization | 256,296 | 42,443 | 36,229 | 27,905 | 38,340 | 55,972 | Upgrade
|
| Market Cap Growth | 169.97% | 17.15% | 29.83% | -27.22% | -31.50% | -0.39% | Upgrade
|
| Enterprise Value | - | 48,445 | 43,620 | 36,761 | 49,208 | 69,151 | Upgrade
|
| Last Close Price | 9260.00 | 1581.88 | 1318.83 | 992.31 | 1318.31 | 1788.54 | Upgrade
|
| PE Ratio | 153.47 | 30.00 | - | 53.65 | 12.92 | 33.50 | Upgrade
|
| PS Ratio | 2.37 | 0.39 | 0.35 | 0.24 | 0.34 | 0.46 | Upgrade
|
| PB Ratio | 2.53 | 0.42 | 0.36 | 0.27 | 0.41 | 0.60 | Upgrade
|
| P/TBV Ratio | 2.59 | 0.43 | 0.37 | 0.28 | 0.42 | 0.61 | Upgrade
|
| P/FCF Ratio | 44.89 | 7.43 | - | 10.79 | - | - | Upgrade
|
| P/OCF Ratio | 32.23 | 5.34 | - | 4.45 | 14.32 | - | Upgrade
|
| EV/Sales Ratio | - | 0.45 | 0.43 | 0.32 | 0.44 | 0.56 | Upgrade
|
| EV/EBITDA Ratio | - | 11.27 | - | 6.20 | 35.00 | 18.32 | Upgrade
|
| EV/EBIT Ratio | - | 22.15 | - | 10.62 | - | 59.08 | Upgrade
|
| EV/FCF Ratio | - | 8.49 | - | 14.22 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.21 | 0.29 | 0.27 | 0.24 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 4.83 | 4.83 | - | 4.69 | 15.65 | 6.23 | Upgrade
|
| Debt / FCF Ratio | 3.63 | 3.63 | - | 10.76 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.06 | 0.06 | 0.13 | 0.13 | 0.12 | 0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.42 | 1.42 | -6.46 | 2.34 | 7.60 | 4.20 | Upgrade
|
| Net Debt / FCF Ratio | 1.07 | 1.07 | -3.05 | 5.36 | -8.43 | -1.72 | Upgrade
|
| Asset Turnover | 0.74 | 0.74 | 0.67 | 0.79 | 0.84 | 0.93 | Upgrade
|
| Inventory Turnover | 3.00 | 3.00 | 3.07 | 4.41 | 4.42 | 4.89 | Upgrade
|
| Quick Ratio | 1.62 | 1.62 | 1.41 | 1.55 | 1.80 | 1.64 | Upgrade
|
| Current Ratio | 2.20 | 2.20 | 1.97 | 1.94 | 2.21 | 2.07 | Upgrade
|
| Return on Equity (ROE) | 1.45% | 1.45% | -4.75% | 0.55% | 3.21% | 1.80% | Upgrade
|
| Return on Assets (ROA) | 0.93% | 0.93% | -1.76% | 1.50% | -0.42% | 0.55% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.04% | 1.99% | -3.75% | 0.95% | -0.65% | 0.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 2.00% | -4.10% | 3.10% | -0.90% | 1.20% | Upgrade
|
| Earnings Yield | 0.55% | 3.33% | -13.39% | 1.86% | 7.74% | 2.99% | Upgrade
|
| FCF Yield | 2.23% | 13.45% | -11.47% | 9.27% | -3.31% | -16.46% | Upgrade
|
| Dividend Yield | 0.32% | - | - | - | 3.41% | 2.80% | Upgrade
|
| Payout Ratio | 62.32% | 62.32% | - | 202.97% | 41.25% | 95.71% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | 0.90% | 0.97% | 2.94% | 7.44% | Upgrade
|
| Total Shareholder Return | 0.21% | -0.08% | 0.90% | 0.97% | 6.35% | 10.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.